Sell 2/3/2025Upgraded
Ondine Biomedical Inc. (OBIMF) was upgraded to E+ from E on 2/3/2025 due to an increase in the volatility index and growth index.

Sell 11/4/2024Upgraded
Ondine Biomedical Inc. (OBIMF) was upgraded to E from E- on 11/4/2024 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0119 to -$0.0117, operating cash flow increased 1.47% from -$2.63M to -$2.59M, and EBIT increased 1.47% from -$2.9M to -$2.86M.

Sell 7/31/2024None
Ondine Biomedical Inc. (OBIMF) was downgraded to E- from U on 07/31/2024.